New Research Supports Surgery as a Second-Line Mesothelioma Treatment, According to Surviving Mesothelioma

Share Article

Scientists say mesothelioma patients who have surgery again after their pleural mesothelioma recurs have better odds of survival than patients who have other types of second-line treatments.

Treatment for Mesothelioma Recurrence

Surgery After Mesothelioma Relapse

The median post-recurrence survival (PRS) after surgery was significantly longer than that of patients receiving chemo-, radio-, or chemo-radiotherapy.

A team of Swiss doctors has released a report on mesothelioma relapse and the most effective ways to treat it. Surviving Mesothelioma has just posted the findings on the website. Click here to read the details now.

Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who relapsed, surgery appeared to be the most effective second-line mesothelioma treatment.

“The median post-recurrence survival (PRS) after surgery was significantly longer than that of patients receiving chemo-, radio-, or chemo-radiotherapy,” writes the study’s lead author Arthur Kostron, MD.

According to their report in the European Journal of Cardiothoracic Surgery, the team also found that three quarters of mesothelioma patients with recurrent disease developed new tumors in the original spot. More than half of those also developed tumors in new locations.

“By providing an in-depth look at the patterns of mesothelioma recurrence, it is hoped that this research will be a stepping stone to develop new and better second-line treatments,” says Surviving Mesothelioma Managing Editor Alex Strauss.

For more information on mesothelioma recurrence and treatments, see Second Surgery May Prolong Mesothelioma Survival, now available on the Surviving Mesothelioma website.

Kostron, A, et al, “Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma”, November 20, 2015, European Journal of Cardiothoracic Surgery, Epub ahead of print,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website